Drug discovery using chemical systems biology: identification of the protein-ligand binding network to explain the side effects of CETP inhibitors.
Systematic identification of protein-drug interaction networks is crucial to correlate complex modes of drug action to clinical indications. We introduce a novel computational strategy to identify protein-ligand binding profiles on a genome-wide scale and apply it to elucidating the molecular mechan...
Main Authors: | Li Xie, Jerry Li, Lei Xie, Philip E Bourne |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2009-05-01
|
Series: | PLoS Computational Biology |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19436720/pdf/?tool=EBI |
Similar Items
-
Drug discovery using chemical systems biology: weak inhibition of multiple kinases may contribute to the anti-cancer effect of nelfinavir.
by: Li Xie, et al.
Published: (2011-04-01) -
Measurement of LDL-C after treatment with the CETP inhibitor anacetrapib[S]
by: Michael Davidson, et al.
Published: (2013-02-01) -
Insights into the binding mode of MEK type-III inhibitors. A step towards discovering and designing allosteric kinase inhibitors across the human kinome.
by: Zheng Zhao, et al.
Published: (2017-01-01) -
Anacetrapib, a New CETP Inhibitor: The New Tool for the Management of Dyslipidemias?
by: Theodosios D. Filippatos, et al.
Published: (2017-09-01) -
Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro
by: Laura K. Potter, et al.
Published: (2009-11-01)